|
Volumn 36, Issue 5, 2000, Pages 1500-1506
|
A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: The Serial Markers, Acute Myocardial Infarction and Rapid Treatment Trial (SMARTT)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATINE KINASE MB;
FIBRINOLYTIC AGENT;
MYOGLOBIN;
ACUTE HEART INFARCTION;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EMERGENCY TREATMENT;
FEMALE;
FIBRINOLYTIC THERAPY;
HOSPITAL ADMISSION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ST SEGMENT ELEVATION;
BIOLOGICAL MARKERS;
CREATINE KINASE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
MYOCARDIAL REPERFUSION;
MYOGLOBIN;
TIME FACTORS;
|
EID: 0034332684
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(00)00897-4 Document Type: Article |
Times cited : (27)
|
References (29)
|